Mill Creek Capital Advisors, LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1964962
Conshohocken, PA
Position in GILD
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$384,800
+$43,706 QoQ
Shares Held
2,761
-0.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Mill Creek Capital Advisors, LLC holds $59,193,747 across 6 Drug Manufacturers - General names. GILD ranks #6 (0.7% of the industry book) .
All Filings in GILD
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $384,800 | 2,761 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $341,094 | 2,779 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $303,030 | 2,730 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $286,155 | 2,581 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $292,002 | 2,606 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $238,406 | 2,581 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $232,069 | 2,768 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $205,349 | 2,993 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $296,982 | 3,666 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $217,251 | 2,899 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $264,812 | 3,436 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $227,337 | 2,740 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $236,602 | 2,756 | Shares | Sole | 2023-05-25 | |
| No filing history on record for this holder in this stock. | ||||||